IMGN Related Guidance
-
Immunogen, Inc. (IMGN) Tops Q3 EPS by 13c; Sees Wider FY13 Loss
-
Immunogen, Inc. (IMGN) Tops Q4 EPS by 1c; Guides FY13 Loss
-
ImmunoGen (IMGN) Investors Cheer Lilly Deal Despite Expected Larger FY Loss
-
Immunogen Inc. (IMGN) Posts Q1 Loss of $0.19, Beats by 4c; Sees FY10 Net Loss
-
ImmunoGen (IMGN) Reports a Q2 Loss; Comments on FY Outlook
-
ImmunoGen (IMGN) Misses Q3 EPS by 2c; CFO Comments on Outlook
-
Immunogen Inc. (IMGN) Posts Q1 Loss of $0.22; Reaffirms Guidance
-
ImmunoGen (IMGN) Reports a Q2 Loss, Updates FY08 Guidance
Back to IMGN Stock Lookup
